BeiGene's hema­tol­ogy CMO is on her way out amid mar­ket tur­moil

Af­ter six years in the role, BeiGene’s hema­tol­ogy CMO has an­nounced her up­com­ing de­par­ture.

The biotech kept it short in an 8-K filed yes­ter­day, but here’s what we know: Jane Huang, fea­tured in our Top 20 Women in Bio­phar­ma spe­cial re­port just three months ago, ten­dered her res­ig­na­tion and gave 30 days no­tice on Wednes­day — and she will be no longer work­ing as an em­ploy­ee af­ter April 3. No rea­son was giv­en for her de­par­ture, and there has been no men­tion of who her re­place­ment will be.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER